BPH Global Registry
A Global Registry of Treatments and Outcomes for Benign Prostatic Hyperplasia
Société Internationale d'Urologie
7,500 participants
Mar 13, 2023
OBSERVATIONAL
Conditions
Summary
Benign prostatic hyperplasia (BPH) is one of the most common performed surgical procedures in urology. Over the past few decades there have been an increasing development of newer surgical treatment options. Additionally, the outcome parameters for BPH treatments have been standardized. While data are available for the initial pivotal studies, post-market release data are lacking. Under the umbrella of uCARE, we have started a prospective, ongoing international registry for recording demographics and outcomes for patients undergoing surgical treatments for BPH.
Eligibility
Inclusion Criteria1
- Primary diagnosis of BPH with LUTS with prescribed medical treatment or surgical intervention
Exclusion Criteria2
- Non-symptomatic BPH
- No treatment prescribed for BPH
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(26)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05543200